SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-23-002795
Filing Date
2023-01-13
Accepted
2023-01-13 16:15:48
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea171452-s3_hoththerape.htm S-3 313189
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP AS TO THE LEGALITY OF THE SEC ea171452ex5-1_hoththerape.htm EX-5.1 14812
3 CONSENT OF WITHUMSMITH+BROWN, PC ea171452ex23-1_hoththerape.htm EX-23.1 2344
4 FILING FEE TABLE ea171452ex-fee_hoththerape.htm EX-FILING FEES 12344
5 GRAPHIC image_001.jpg GRAPHIC 10930
6 GRAPHIC image_002.jpg GRAPHIC 38536
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3438
  Complete submission text file 0001213900-23-002795.txt   416916
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269224 | Film No.: 23528946
SIC: 2834 Pharmaceutical Preparations